Inhaled corticosteroid (ICS) therapy carries less risk of complicating drug-or disease-related
morbidity and mortality than that associated with other antiasthmatic drugs such as …

The systemic activity and safety of inhaled corticosteroids are best studied in randomized,
controlled, long-term trials with clinically relevant doses in subjects. These studies require …

The therapeutic ratio for inhaled corticosteroid therapy is determined by the relative dose-
response relationships for anti-asthmatic clinical efficacy and systemic adverse effects. In …

The purpose of this review is to provide the clinician with an update on the potential adverse
effects caused by the inhaled corticosteroids (ICSs). The systemic effects of ICSs are a result …

Inhaled corticosteroids play a pivotal role in the treatment of asthma. Inhalation permits
effective delivery of the corticosteroid in high concentration to target sites within the lung …

Inhaled corticosteroids are established as the mainstay of maintenance therapy for chronic
asthma. However, there remains some debate regarding the safety of long-term use of these …

Inhaled corticosteroids are being given to more patients, at increasing doses and for longer
periods of time. This has led to renewed concern about side-effects, particularly when higher …

Inhaled corticosteroids are considered by many to be the anti-inflammatory therapy of choice
in adult asthma, given their remarkable efficacy and apparent safety. They are presently …

Inhaled corticosteroids are a first-line therapy for persistent asthma in children. Major safety
concerns of long-term inhaled corticosteroid therapy include suppression of adrenal …

Inhaled corticosteroids remain the most important therapy for chronic asthma in both adults
and children. As all inhaled corticosteroids act by binding to a common glucocorticoid …